Aarti Drugs Ltd share price logo

Aarti Drugs Ltd Share Price

NSE: AARTIDRUGS

BSE: 524348

Small Cap

Healthcare Sector

₹507.75

-8.15

(-1.58%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Aarti Drugs Ltd Stock Performance

as on October 23, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹505
    ₹518.5
    downward going graph

    0.54%

    Downside

    2.12%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹312
    ₹564.05
    downward going graph

    38.55%

    Downside

    11.09%

    Upside

    downward going graph

Aarti Drugs Ltd share price movements today

Previous Close
₹515.90
Open
₹518.50
Volume
81.36K
Upper Circuit
₹619.05
Lower Circuit
₹412.75
Day's Low - High
₹505 - ₹518.5
52 Week Low - High
₹312 - ₹564.05

Aarti Drugs Ltd Historical Returns

1 Month Return
+ 0.01 %
3 Month Return
-3.5 %
1 Year Return
+ 5.7 %
3 Year Return
+ 12.8 %
5 Year Return
-31.24 %

Aarti Drugs Ltd Fundamentals

as on October 23, 2025 at 4:01 pm IST

Market Cap

₹4,742.93 Cr

Return on Equity (ROE)

12.97

PE Ratio (TTM)

24.95

Return on capital employed (ROCE)

13.49

Industry PE ratio

42.13

Beta (LTM)

0.86

P/B Ratio

2.48

Dividend Yield

0.29

PEG Ratio

6.87

Quarterly Earnings Growth YOY

62.22

EPS (TTM)

18.42

Sector

Pharmaceuticals

Book Value

149.99

Technical Analysis

Bullish

View Technical Analysis

Aarti Drugs Ltd Stock Valuation

as on October 23, 2025 at 4:01 pm IST

Aarti Drugs Ltd in the last 5 years

  • Overview

  • Trends

Lowest (8.29x)

March 31, 2020

Today (24.95x)

October 21, 2025

Industry (42.13x)

October 21, 2025

Highest (57.24x)

August 24, 2020

LowHigh

Today’s Price to Earnings Ratio: 24.95x

Aarti Drugs Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Aarti Drugs Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Aarti Drugs Ltd image
Aarti Drugs Ltd
BUY4,742.93-6.25%0.661682,387
Cohance Lifesciences Ltd image
Cohance Lifesciences Ltd
BUY34,366.0132.66%0.682641,197
Jubilant Pharmova Ltd image
Jubilant Pharmova Ltd
BUY18,219.1413.96%0.718367,234
Sun Pharma Advanced Research Company Ltd image
Sun Pharma Advanced Research Company Ltd
NA4,277.19-4.61%1.88-34371
Rainbow Childrens Medicare Ltd image
Rainbow Childrens Medicare Ltd
BUY13,812.0540.42%0.672441,515
See all

Analyst Recommendation on Aarti Drugs Ltd Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Aarti Drugs Ltd. Average target price of ₹628

Source: S&P Global Market Intelligence

Aarti Drugs Ltd Share Price Target

Get share price movements and forecasts by analysts on Aarti Drugs Ltd.

What analysts predicted

21.73%UPSIDE

Target Price

₹628

Current Price

₹507.75

Analyzed by

1 Analysts

High

₹628

Target

₹628.00

Low

₹628

Aarti Drugs Ltd target price ₹628, a slight upside of 21.73% compared to current price of ₹507.75. According to 1 analysts rating.

Source: S&P Global Market Intelligence

Aarti Drugs Ltd Stock’s Investor Sentiment and Interest

Search interest for Aarti Drugs Ltd Stock has decreased by -25% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-25% versus previous 30 day period

Aarti Drugs Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sales
663.96
742.41
661.11
641.54
605.94
619.99
555.34
598.33
556.6
676.76
590.51
Other Income
1.01
0.87
0.6
0.69
1.67
1.08
1.11
1.48
11.9
1.87
0.31
Total Income
664.97
743.28
661.71
642.23
607.61
621.07
556.45
599.81
568.5
678.63
590.82
Expenses
593.31
648.87
577.04
565.1
535.8
534.18
490.38
531.28
494.88
583.43
516.43
Operating Profit
70.65
93.54
84.07
76.44
70.14
85.81
64.96
67.05
61.72
93.33
74.08
Operating Profit Margin %
10.64%
12.6%
12.72%
11.92%
11.58%
13.84%
11.7%
11.21%
11.09%
13.79%
12.55%
Profit Before Interest, Tax and Depreciation
71.66
94.41
84.67
77.13
71.81
86.89
66.07
68.53
73.62
95.2
74.39
Interest
9.36
8.63
8.54
8.25
7.6
9.13
8.71
8.93
9.07
9.16
8.56
Depreciation
12.62
12.5
12.6
12.61
12.66
13.58
13.38
13.72
13.8
14.88
14.72
Profit Before Tax
49.68
73.28
63.53
56.27
51.55
64.18
43.98
45.88
50.75
71.16
51.11
Tax Paid
13.01
17.1
15.56
16.67
14.84
16.87
10.71
10.92
13.66
8.39
-2.86
Profit After Tax
36.67
56.18
47.97
39.6
36.71
47.31
33.27
34.96
37.09
62.77
53.97
Total Net profit including share of profit / Loss from associate company
36.67
56.18
47.97
39.6
36.71
47.31
33.27
34.96
37.09
62.77
53.97
EPS
3.96
6.07
5.18
4.29
3.99
5.15
3.62
3.83
4.06
6.88
5.91
Actual EPS
3.96
6.07
5.18
4.29
3.99
5.15
3.62
3.83
4.06
6.88
5.91
Adjusted EPS
3.96
6.07
5.18
4.29
3.99
5.15
3.62
3.83
4.06
6.88
5.91
Diluted EPS
3.96
6.07
5.18
4.29
3.99
5.15
3.62
3.83
4.06
6.88
5.91

Aarti Drugs Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
1,195.17
1,243.63
1,560.94
1,806.09
2,154.78
2,488.65
2,716.05
2,528.58
2,387.03
Other Income
4
1.05
6.18
5.95
4.74
11.32
2.19
4.03
16.36
Total Income
1,199.17
1,244.68
1,567.12
1,812.04
2,159.52
2,499.97
2,718.24
2,532.61
2,403.39
Expenses
1,008.28
1,045.15
1,353.58
1,544.27
1,717.67
2,159.21
2,410.45
2,212.12
2,099.96
Operating Profit
186.89
198.48
207.36
261.82
437.11
329.44
305.6
316.46
287.07
Operating Profit Margin %
15.64%
15.96%
13.28%
14.5%
20.29%
13.24%
11.25%
12.52%
12.03%
Profit Before Interest, Tax and Depreciation
190.89
199.53
213.54
267.77
441.85
340.76
307.79
320.49
303.43
Interest
36.42
34.96
39.96
33.73
22.96
20.75
33.29
33.52
35.87
Depreciation
38.46
40.06
42.56
48.75
49.88
50.05
50.32
51.45
55.78
Profit Before Tax
116.01
124.51
131.02
185.29
369.01
269.96
224.18
235.52
211.78
Tax Paid
34.21
42.2
41.27
43.89
88.61
64.96
57.82
63.93
43.68
Profit After Tax
81.8
82.31
89.75
141.4
280.4
205
166.36
171.59
168.1
Total Net profit including share of profit / Loss from associate company
81.8
82.31
89.75
141.4
280.4
205
166.36
171.59
168.1
EPS
33.46
34.41
38.48
60.57
30.09
22.12
17.97
18.56
18.35
Actual EPS
33.46
34.41
38.48
60.57
30.09
22.12
17.97
18.56
18.35
Adjusted EPS
8.37
8.6
9.62
15.14
30.09
22.12
17.97
18.56
18.35
Diluted EPS
33.46
34.41
38.48
60.57
30.09
22.12
17.97
18.56
18.35

Aarti Drugs Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
133.3
174.75
69.77
143.09
250.74
154.95
70.41
133.32
358.92
244.58
Cash Flow from Investing Activities
-98.79
-106.97
-73.54
-61.67
-33.21
-71.77
-149.63
-163.97
-223.64
-164.63
Cash Flow from Financing Activities
-33.26
-68.22
3.92
-80.06
-215.42
-81.14
92.02
16.55
-136.03
-82.12
Net Cash Flow
1.24
-0.45
0.15
1.35
2.13
2.04
12.8
-14.11
-0.76
-2.17

Mutual Funds that own Aarti Drugs Ltd Stock

Check out the Mutual Funds with significant holdings in Aarti Drugs Ltd.

Aarti Drugs Ltd Corporate Actions

View detailed summary of the earnings and dividend history of Aarti Drugs Ltd.

  • Aarti Drugs Ltd Earnings Results

    Aarti Drugs Ltd’s net profit jumped 62.18% since last year same period to ₹53.91Cr in the Q1 2025-2026. On a quarterly growth basis, Aarti Drugs Ltd has generated -14.24% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Aarti Drugs Ltd Dividends January,2025

    In the quarter ending December 2024, Aarti Drugs Ltd has declared dividend of ₹1.00 per share on 29 Jan 2025 - translating a dividend yield of 0.19%.

    Read More about Dividends

Indices Featuring Aarti Drugs Ltd Stock

Check stock indices that include Aarti Drugs Ltd.

BSE Healthcare

₹45,221.58

-0.46 (▲-209.56%)

BSE Small-Cap

₹53,616.71

-0.42 (▲-226.14%)

Insights on Aarti Drugs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 32.57% to 32.58% in Jun 2025 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 8.75% to 9.85% in Jun 2025 quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 2.25% to 2.26% in Jun 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 129.1% return, outperforming this stock by 116.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 15.0% return, outperforming this stock by 9.3%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 678.63 Cr → 590.82 Cr (in ₹), with an average decrease of 12.9% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 62.86 Cr → 53.91 Cr (in ₹), with an average decrease of 14.2% per quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 55.48% to 55.22% in Jun 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, AARTIDRUGS stock has moved down by -1.7%

About Aarti Drugs Ltd

Aarti Drugs Limited is a leading manufacturer of Active Pharmaceutical Ingredients (API), Pharma Intermediates and Specialty Chemicals. Part of the USD 1500 million Aarti Group, it has two RD divisions in Tarapur and Turbhe, Maharashtra; and three wholly-owned subsidiaries, namely Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited and Pinnacle Chile SpA, a foreign subsidiary. It has expanded its production capacity from 598,000kg in 1993 to 25,716,000kg in 2021. In 2020 it incorporated two overseas subsidiaries and one domestic one, while the one in 2021 was wound up as it didn’t have any business activity. Aarti Drugs also carries out research and development on key products such as antihistaminic/antiallergic, antiinflammatory and antidiabetic. Its GMP-certified plant can manufacture Benzene Sulphonyl Chloride, Benzene Sulphonic Acid/ Ammonium/ Sodium Salt and Benzene Sulphonamide. With 50 compounds formed for Antibiotics, Anti Protozoal, AntiInflammatory, Antidiabetic, Anti Fungal and Cardioprotectant therapeutic segments, it is a market leader in API segment.

Revenue: ₹590.51Cr as on June 2025 (Q1 FY26)
Net Profit: ₹53.97Cr as on June 2025 (Q1 FY26)
Listing date: 03 Oct, 1996
Chairperson Name: Prakash M Patil
OrganisationAarti Drugs Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEOPrakash M Patil
E-voting on sharesClick here to vote

FAQs

What is Aarti Drugs Ltd share price today?

Aarti Drugs Ltd share price today stands at ₹507.75 as on at the close of the market. Aarti Drugs Ltd share today touched a day high of ₹518.5 and a low of ₹505.

What is the 52 week high and 52 week low range for Aarti Drugs Ltd share?

Aarti Drugs Ltd touched a 52 week high of ₹564.05 and a 52 week low of ₹312. Aarti Drugs Ltd share price today i.e. is closed at ₹507.75, which is -9.98% down from its 52 week high and 62.74% up from its 52 week low.

What is Aarti Drugs Ltd's market capitalisation today?

Aarti Drugs Ltd market capitalisation is ₹4,742.93 Cr as on .

How to buy Aarti Drugs Ltd shares?

To buy Aarti Drugs Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for AARTIDRUGS or Aarti Drugs Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Aarti Drugs Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Aarti Drugs Ltd trading volume today?

Aarti Drugs Ltd trading volume is 81.36K as on . This means that 81.36K shares of Aarti Drugs Ltd were bought and sold on the stock market during today's trading session.